Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 1 out of 5 16.01

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Caps

How do you think AGEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

199 Outperform
92 Underperform
 

All-Star Players

23 Outperform
31 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top AGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.81)
Submitted April 03, 2013

I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to… More

TerryHogan (99.97)
Submitted October 04, 2018

I think there's a solid industry of creating biotech companies with no hope of real profits and milking/bilking investors. If my parents had been more Bernie Madoff and less Andy Griffith I would definitely start one. 1- Find an aging biology… More

AGEN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about AGEN.

Recs

1
Member Avatar TerryHogan (99.97) Submitted: 10/4/2018 3:14:42 AM : Underperform Start Price: $2.16 AGEN Score: -34.65

I think there's a solid industry of creating biotech companies with no hope of real profits and milking/bilking investors. If my parents had been more Bernie Madoff and less Andy Griffith I would definitely start one. 1- Find an aging biology professor with a couple of published papers tangential to a fadish disease treatment. 2. - Over a dinner and some scotch, convince him he's a genius and together you can be rich and save the world. 3. Look at a few other scammy biotech firms and recruit a board of directors that have 'proven experience'. 4. Raise a bit of capital from some alumni. 5. Go public. 6. Alternate between issuing press releases and issuing shares. 7. Collect large salary & stock options. Not saying that's what's going on with this company, but it definitely is happening out there.

Recs

0
Member Avatar rocknrook (55.81) Submitted: 6/27/2017 7:53:50 AM : Outperform Start Price: $4.01 AGEN Score: -44.57

Assuming effective test results. I like that there is significant interest from big players in partnering.

Recs

2
Member Avatar zzlangerhans (99.81) Submitted: 4/3/2013 1:23:04 AM : Outperform Start Price: $3.94 AGEN Score: -106.22

I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to raise ahead of data. If they do, expect disappointment ahead.

Leaderboard

Find the members with the highest scoring picks in AGEN.

Score Leader

epc53

epc53 (27.78) Score: +283.52

The Score Leader is the player with the highest score across all their picks in AGEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
svande8952 40.65 6/16/2009 Underperform 5Y $12.24 -76.96% +204.46% +281.42 1 Comment
1or5stars 99.71 6/8/2009 Underperform 3W $13.68 -79.39% +200.68% +280.06 0 Comment
TWreckz 99.06 6/5/2009 Underperform 5Y $15.90 -82.26% +195.41% +277.67 0 Comment
rcbaldwinjr 77.78 8/5/2009 Underperform 3W $13.85 -79.64% +181.32% +260.97 0 Comment
rhinomaj 93.04 8/4/2009 Underperform 3M $14.34 -80.33% +179.55% +259.89 0 Comment
epc53 27.78 8/7/2009 Underperform 5Y $13.26 -78.73% +177.97% +256.70 0 Comment
JackOffBadApples 79.52 9/12/2008 Underperform 3W $10.02 -71.86% +131.77% +203.63 0 Comment
chop3399 < 20 3/13/2008 Underperform 5Y $13.44 -79.02% +124.55% +203.56 0 Comment
DayTr8der88 < 20 9/22/2008 Underperform NS $9.90 -71.52% +129.95% +201.47 0 Comment
BadCopNoDonuts < 20 7/28/2010 Underperform 5Y $5.64 -50.00% +150.85% +200.85 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.79 1/9/2015 Outperform 3W $5.29 -46.69% +36.72% -83.41 0 Comment
TrackWMBlair 77.66 1/5/2012 Outperform NS $2.12 +33.02% +118.30% -85.28 0 Comment
trackglobalhunte < 20 12/1/2011 Outperform NS $2.44 +15.57% +123.67% -108.09 0 Comment
trackmlvcapital < 20 9/13/2011 Outperform NS $3.42 -17.54% +138.57% -156.12 0 Comment
TrackDawsonJames < 20 6/1/2011 Outperform NS $5.58 -49.46% +107.61% -157.07 0 Comment
TrackRodmanRen < 20 5/9/2011 Outperform NS $5.75 -50.98% +106.96% -157.94 0 Comment

Advertisement